+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Antimicrobial Wound Care Dressings Market Size, Share and Growth Outlook, 2026: Analysis By Active Ingredient (Silver Antimicrobial Dressings, Iodine / Povidone-Iodine Dressings, Honey-Based Antimicrobial Dressings, Polyhexamethylene Biguanide ), By Dressing Material (Foam Dressings, Alginate Dressings, Hydrogel Dressings , Hydrocolloid Dressings, Film & Sheet Dressings, Composite Dressings), By Wound Type (Chronic Wounds , Acute Wounds ), By End-User (Hospitals , Outpatient Facilities & Specialized Wound Clinics, Home Healthcare Settings & Caregivers) Companies, and Country Forecast, 2021 to 2034

Global Antimicrobial Wound Care Dressings Market size is forecast to increase from $1.85 Billion in 2026 to $3.07 Billion in 2034 at a CAGR of 6.53% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005667
Pages: 211 Pages

Antimicrobial Urinary Catheters Market Size, Share and Growth Outlook, 2026: Analysis By Product Design (Intermittent Catheters, Foley / Indwelling Catheters, External Catheters), By Coating & Antimicrobial Technology (Silver-Based Coatings, Antibiotic-Impregnated Coatings, Hydrophilic & Anti-Fouling Coatings, Nitrofurazone-Impregnated Coatings), By Material Type (Silicone-Based, Latex-Based, Polyvinyl Chloride ), By Patient Gender (Male, Female), By End-User (Hospitals , Long-Term Care Facilities , Home Care Settings, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Antimicrobial Urinary Catheters Market size is forecast to increase from $1.6 Billion in 2026 to $3.01 Billion in 2034 at a CAGR of 8.23% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005666
Pages: 224 Pages

Antimicrobial Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Antibacterial Drugs , Antiviral Drugs, Antifungal Drugs, Antiparasitic Drugs), By Therapy Spectrum (Broad-Spectrum Antimicrobials, Narrow-Spectrum Antimicrobials), By Route of Administration (Oral, Injectable / Parenteral , Topical , Others), By Treatment Modality (Monotherapies, Combination Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online Pharmacies / E-Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Antimicrobial Therapeutics Market size is forecast to increase from $205.86 Billion in 2026 to $330.59 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005665
Pages: 228 Pages

Antimicrobial Susceptibility Testing Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Manual AST Products , Automated AST Instruments, Consumables and Reagents, Software and Services), By Method (Dilution Methods , Disk Diffusion, E-Test , Genotypic Methods, Rapid Phenotypic AST), By Testing Type (Antibacterial Testing, Antifungal Testing, Antiviral Testing, Antiparasitic Testing), By Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Surveillance, Veterinary and Environmental Monitoring), By End User (Hospital Laboratories, Reference and Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Contract Research Organizations , Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antimicrobial Susceptibility Testing Market size is forecast to increase from $4.94 Billion in 2026 to $7.35 Billion in 2034 at a CAGR of 5.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005664
Pages: 221 Pages

Antimicrobial Resistance (AMR) Diagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Molecular Diagnostics , Immunoassays , Mass Spectrometry , Phenotypic Methods , Microfluidics and Biochips), By Application (Clinical Diagnostics , Drug Discovery and Development, Public Health & Pathogen Surveillance, Veterinary and Environmental Testing), By End User (Hospitals and Clinics, Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Public Health and Surveillance Agencies) Companies, and Country Forecast, 2021 to 2034

Global Antimicrobial Resistance (AMR) Diagnostics Market size is forecast to increase from $3.78 Billion in 2026 to $5.5 Billion in 2034 at a CAGR of 4.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005663
Pages: 216 Pages

Antimicrobial Coatings for Medical Devices Market Size, Share and Growth Outlook, 2026: Analysis By Coating Material Class (Metallic Antimicrobial Coatings , Non-Metallic Antimicrobial Coatings ), By Target Device Type (Catheters , Implantable Devices , Surgical Instruments & Consumables, Dental Implants & Prosthetics, Endoscopes & Diagnostic Probes), By Coating Application Method (Liquid / Dip Coating, Spray Coating, Chemical Vapor Deposition , Plasma Treatment / Electroplating), By End-User Type (Original Equipment Manufacturers , Contract Manufacturing Organizations , Specialized Medical Coating Service Providers) Companies, and Country Forecast, 2021 to 2034

Global Antimicrobial Coatings for Medical Devices Market size is forecast to increase from $4.63 Billion in 2026 to $12.48 Billion in 2034 at a CAGR of 13.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005662
Pages: 214 Pages

Antimicrobial Catheters Market Size, Share and Growth Outlook, 2026: Analysis By Catheter Type (Central Venous Catheters, Urinary Catheters, Peripheral Venous Catheters, Arterial & Dialysis Catheters), By Coating & Antimicrobial Technology (Silver-Based & Precious Metal Coatings, Antibiotic-Impregnated Catheters, Hydrophilic / Anti-Fouling Bioactive Coatings, Antiseptic / Chlorhexidine-Impregnated Catheters), By Material (Silicone-Based, Polyurethane & Latex-Based, PVC / Vinyl), By Intended Duration of Use (Short-Term Catheterization, Long-Term Catheterization), By Patient Gender (Male, Female), By End-User (Hospitals , Ambulatory Surgical Centers , Long-Term Care Facilities & Nursing Homes, Home Care Settings) Companies, and Country Forecast, 2021 to 2034

Global Antimicrobial Catheters Market size is forecast to increase from $1.72 Billion in 2026 to $3.35 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005661
Pages: 227 Pages

Anti-malarial Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Artemisinin-Based Combination Therapies , Aminoquinolines, Aryl Amino-Alcohols, Antifolate Compounds, Cinchona Alkaloids, Biguanides & Sulfonamides), By Route of Administration (Oral, Injectable), By Application (Prophylaxis / Prevention, Acute Treatment, Radical Cure), By Malaria Type (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Knowlesi & Others), By Patient Group (Pediatrics & Infants, Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drugstores, Online Pharmacies) Companies, and Country Forecast, 2021 to 2034

Global Anti-malarial Drugs Market size is forecast to increase from $1133.65 Million in 2026 to $1601.09 Million in 2034 at a CAGR of 4.41% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005660
Pages: 214 Pages

Anti-inflammatory Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Anti-Inflammatory Biologics, Nonsteroidal Anti-Inflammatory Drugs , Corticosteroids, Disease-Modifying Antirheumatic Drugs ), By Indication (Arthritis , Respiratory Diseases , Psoriasis and Dermatological Inflammations, Inflammatory Bowel Disease , Multiple Sclerosis, Gout and Other Inflammatory Conditions), By Route of Administration (Oral Formulations, Injection , Topical ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Drugstores, Online) Companies, and Country Forecast, 2021 to 2034

Global Anti-inflammatory Therapeutics Market size is forecast to increase from $119.81 Billion in 2026 to $199.78 Billion in 2034 at a CAGR of 6.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005659
Pages: 215 Pages

Anti-inflammatory Peptides Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Natural Anti-inflammatory Peptides , Synthetic and Recombinant Anti-inflammatory Peptides, Peptidomimetics), By Route of Administration (Parenteral , Topical , Oral Formulations, Pulmonary and Nasal), By Application (Cardiovascular Diseases, Autoimmune and Inflammatory Disorders, Dermatological Conditions, Gastrointestinal Disorders, Respiratory Diseases), By End-User (Hospitals and Specialized Clinics, Pharmaceutical and Biotechnology Companies, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Anti-inflammatory Peptides Market size is forecast to increase from $926.59 Million in 2026 to $1354.46 Million in 2034 at a CAGR of 4.86% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005658
Pages: 225 Pages